| Financial Year |
March 31 2023 |
| Monetary Funds |
351,552,472.65 |
| Held-for-trading Financial Assets |
427,490,783.69 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,174,282,776.75 |
| Advances to Suppliers |
3,613,340.94 |
| Other Receivables |
30,039,240.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
17,194,988.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,061,011.26 |
| Total Current Assets |
2,666,851,206.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
53,892,868.12 |
| Under-construction Projects |
127,539.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
596,688.33 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,861,884.01 |
| Deferred Income Tax Assets |
19,896,951.40 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
114,196,896.99 |
| Total Assets |
2,781,048,103.11 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
6,434,503.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
294,966,582.83 |
| Taxes Payable |
117,159,862.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,428,368.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,136,721.78 |
| Other Current Liabilities |
643,170.61 |
| Sub-Total of Current Liabilities |
469,488,720.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,705,519.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,997,451.33 |
| Total Liabilities |
496,486,171.33 |
| Paid-In Capital(Or Share Stock) |
314,898,267.00 |
| Capital Surplus |
895,105,597.92 |
| Surplus Reserve |
115,902,311.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
958,655,755.78 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,284,561,931.78 |
| Owner's Equity（Stockholder's Equity） |
2,284,561,931.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,781,048,103.11 |
